# Gilles Montalescot

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gilles-montalescot/

## Facts

| Field | Value |
| --- | --- |
| Citations | 80,499 |
| Field | Acute Myocardial Infarction Research |
| h-index | 118 |
| i10-index | 488 |
| Last Known Institution | Maastricht University Medical Centre |
| OpenAlex ID | https://openalex.org/A5027244910 |
| ORCID iD | https://orcid.org/0000-0003-0824-6809 |
| Works | 1,121 |

## Researcher papers

Showing 12 of 15.

- [2018 ESC/EACTS Guidelines on myocardial revascularization](https://scholariq.org/papers/2018-esc-eacts-guidelines-on-myocardial-revascularization/)
- [Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes](https://scholariq.org/papers/prasugrel-versus-clopidogrel-in-patients-with-acute-coronary-syndromes/)
- [2014 ESC/EACTS Guidelines on myocardial revascularization](https://scholariq.org/papers/2014-esc-eacts-guidelines-on-myocardial-revascularization/)
- [2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS](https://scholariq.org/papers/2017-esc-focused-update-on-dual-antiplatelet-therapy-in-coronary-artery-disease/)
- [Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events](https://scholariq.org/papers/clopidogrel-and-aspirin-versus-aspirin-alone-for-the-prevention-of/)
- [Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation](https://scholariq.org/papers/addition-of-clopidogrel-to-aspirin-and-fibrinolytic-therapy-for-myocardial/)
- [PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock](https://scholariq.org/papers/pci-strategies-in-patients-with-acute-myocardial-infarction-and-cardiogenic/)
- [Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial](https://scholariq.org/papers/prasugrel-compared-with-clopidogrel-in-patients-undergoing-percutaneous-coronary/)
- [2018 ESC/EACTS Guidelines on myocardial revascularization](https://scholariq.org/papers/2018-esc-eacts-guidelines-on-myocardial-revascularization-2/)
- [Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease](https://scholariq.org/papers/evacetrapib-and-cardiovascular-outcomes-in-high-risk-vascular-disease/)
- [Intravenous Platelet Blockade with Cangrelor during PCI](https://scholariq.org/papers/intravenous-platelet-blockade-with-cangrelor-during-pci/)
- [Impact of age on management and outcome of acute coronary syndrome: Observations from the global registry of acute coronary events (GRACE)](https://scholariq.org/papers/impact-of-age-on-management-and-outcome-of-acute-coronary-syndrome-observations/)

## Researcher topics

- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)

## Researcher university

- [Maastricht University Medical Centre](https://scholariq.org/institutions/maastricht-university-medical-centre/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.